173 related articles for article (PubMed ID: 23007682)
21. Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells.
Leslie CC; McCormick-Shannon K; Shannon JM; Garrick B; Damm D; Abraham JA; Mason RJ
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):379-87. PubMed ID: 9115748
[TBL] [Abstract][Full Text] [Related]
22. Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.
Sakai M; Zhang M; Homma T; Garrick B; Abraham JA; McKanna JA; Harris RC
J Clin Invest; 1997 May; 99(9):2128-38. PubMed ID: 9151785
[TBL] [Abstract][Full Text] [Related]
23. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
24. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.
Nishi E; Prat A; Hospital V; Elenius K; Klagsbrun M
EMBO J; 2001 Jul; 20(13):3342-50. PubMed ID: 11432822
[TBL] [Abstract][Full Text] [Related]
25. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
[TBL] [Abstract][Full Text] [Related]
26. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments.
Besner GE; Whelton D; Crissman-Combs MA; Steffen CL; Kim GY; Brigstock DR
Growth Factors; 1992; 7(4):289-96. PubMed ID: 1306684
[TBL] [Abstract][Full Text] [Related]
27. Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like Growth Factor.
Takazaki R; Shishido Y; Iwamoto R; Mekada E
J Biol Chem; 2004 Nov; 279(45):47335-43. PubMed ID: 15331606
[TBL] [Abstract][Full Text] [Related]
28. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes.
Hashimoto K; Higashiyama S; Asada H; Hashimura E; Kobayashi T; Sudo K; Nakagawa T; Damm D; Yoshikawa K; Taniguchi N
J Biol Chem; 1994 Aug; 269(31):20060-6. PubMed ID: 8051092
[TBL] [Abstract][Full Text] [Related]
29. Heparin-binding EGF-like growth factor: a juxtacrine growth factor.
Iwamoto R; Mekada E
Cytokine Growth Factor Rev; 2000 Dec; 11(4):335-44. PubMed ID: 10959080
[TBL] [Abstract][Full Text] [Related]
30. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
32. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
Göőz M; Göőz P; Luttrell LM; Raymond JR
J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor.
no M; Raab G; Lau K; Abraham JA; Klagsbrun M
J Biol Chem; 1994 Dec; 269(49):31315-21. PubMed ID: 7983076
[TBL] [Abstract][Full Text] [Related]
35. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.
Mitamura T; Higashiyama S; Taniguchi N; Klagsbrun M; Mekada E
J Biol Chem; 1995 Jan; 270(3):1015-9. PubMed ID: 7836353
[TBL] [Abstract][Full Text] [Related]
36. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site.
Suzuki M; Raab G; Moses MA; Fernandez CA; Klagsbrun M
J Biol Chem; 1997 Dec; 272(50):31730-7. PubMed ID: 9395517
[TBL] [Abstract][Full Text] [Related]
38. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
39. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.
Thompson SA; Higashiyama S; Wood K; Pollitt NS; Damm D; McEnroe G; Garrick B; Ashton N; Lau K; Hancock N
J Biol Chem; 1994 Jan; 269(4):2541-9. PubMed ID: 8300582
[TBL] [Abstract][Full Text] [Related]
40. Production of monoclonal antibodies with specificity for different epitopes on the human epidermal growth factor molecule.
Yoshitake Y; Nishikawa K
Arch Biochem Biophys; 1988 Jun; 263(2):437-46. PubMed ID: 2454080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
